NCT05527951

Brief Summary

Measurement-based care (MBC) is an evidence-based practice that incorporates routine outcome assessment using validated rating scales to guide collaborative clinical decision-making. Although MBC results in improved outcomes for patients with major depressive disorder (MDD), there are barriers to its broad implementation in clinical settings. The use of "enhanced" MBC (eMBC), with mobile apps that allow patients to track outcomes and engage in self-management via WeChat, may address some of these barriers. The investigators hypothesize that implementation with eMBC using WeChat will be superior to standard MBC implementation using paper-pencil assessments at the clinic, for both implementation and clinical outcomes.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,200

participants targeted

Target at P75+ for not_applicable major-depressive-disorder

Timeline
Completed

Started Sep 2022

Shorter than P25 for not_applicable major-depressive-disorder

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 11, 2022

Completed
23 days until next milestone

Study Start

First participant enrolled

September 3, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 6, 2022

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2022

Completed
Last Updated

September 21, 2022

Status Verified

July 1, 2022

Enrollment Period

4 months

First QC Date

August 11, 2022

Last Update Submit

September 16, 2022

Conditions

Keywords

measurement-based carescalesassessmentdepressionrandomizedcluster trialimplementationmobile healthWeChatclinical trialmixed methodsChina

Outcome Measures

Primary Outcomes (2)

  • Patient Health Questionnaire-9 (PHQ-9)

    To evaluate the severity of depressive symptoms by patients. Remission: total score ≤ 4.

    up to 6 months

  • Proportion of patients with a Patient Health Questionnaire-9 (PHQ-9) score

    Proportion of patients with a PHQ-9 score entered in the clinical record.

    up to 6 months

Secondary Outcomes (11)

  • Patient Health Questionnaire-9(PHQ-9) change scores

    up to 6 months

  • The Sheehan disability scale (SDS)

    up to 6 months

  • Quality of Life scale (QOL-6)

    up to 6 months

  • EuroQoL 5 Dimensions (EQ-5D)

    up to 6 months

  • Health economic assessment (HEA)

    up to 6 months

  • +6 more secondary outcomes

Study Arms (2)

Enhanced MBC Implementation(eMBC)

EXPERIMENTAL

The eMBC implementation arm use our WeChat Easy to Recover from Depression Mini-Program, which consists of mood tracking and lay-coached self-management.

Other: eMBC

Standard MBC Implementation

ACTIVE COMPARATOR

The standard MBC implementation arm use paper and pencil questionnaires.

Other: standard MBC

Interventions

eMBCOTHER

The experimental group will implement eMBC with our WeChat Easy to Recover from Depression Mini-Program, which consists of mood tracking and lay-coached self-management.

Enhanced MBC Implementation(eMBC)

The control intervention group will implement standard MBC using paper and pencil questionnaires.

Standard MBC Implementation

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Men or women aged 18-65 years;
  • Participants were diagnosed of unipolar depressive disorder by the treating physician based on accepted diagnostic criteria (e.g., CCMD-3, DSM-IV, DSM-5, ICD-10);
  • Participants are expected to have a smartphone device available and be proficient in using a smartphone;
  • Participants should have a junior high school education or above, have sufficient audio-visual skills, be able to fully understand the research content and have the legal ability to sign informed consent.

You may not qualify if:

  • Presence of obvious violent aggressive behavior or tendencies;
  • Participants who are unstable during onset episodes and cannot cooperate in completing the study content;
  • Serious suicidal tendencies;
  • Inability to carry out effective verbal communication;
  • No smartphone;
  • Other circumstances that prevented cooperation or completion of the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shanghai Mental Health Center

Shanghai, Shanghai Municipality, 200030, China

RECRUITING

Related Publications (1)

  • Lam RW, Michalak EE, Murphy JK, Colquhoun H, Ng C, Culpepper L, Dewa CS, Greenshaw AJ, He Y, Kennedy SH, Li X, Liu J, Liu T, Parikh S, Soares CN, Wang Z, Xu Y, Chen J. Standard Versus Enhanced Measurement-Based Care Effectiveness for Depression (EMBED): Protocol for a Cluster Randomized Implementation-Effectiveness Trial. Cureus. 2025 Aug 18;17(8):e90395. doi: 10.7759/cureus.90395. eCollection 2025 Aug.

MeSH Terms

Conditions

Depressive Disorder, MajorDepression

Condition Hierarchy (Ancestors)

Depressive DisorderMood DisordersMental DisordersBehavioral SymptomsBehavior

Study Officials

  • Jun Chen, M.D., Ph.D

    Shanghai Mental Health Center(SMHC)

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jun Chen, M.D., Ph.D

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: The study protocol involves a 2-arm cluster RCT of enhanced versus standard measurement-based care implementation for depression.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 11, 2022

First Posted

September 6, 2022

Study Start

September 3, 2022

Primary Completion

December 31, 2022

Study Completion

December 31, 2022

Last Updated

September 21, 2022

Record last verified: 2022-07

Data Sharing

IPD Sharing
Will not share

Locations